UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project

Journal of clinical oncology, 2020-06, Vol.38 (17), p.1906-1918

2020

Volltextzugriff (PDF)

Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4548-4554

2011

Volltextzugriff (PDF)

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor

Journal of clinical oncology, 2023-01, Vol.41 (3), p.508-516

2023

Volltextzugriff (PDF)

Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4107-4118

2022

Volltextzugriff (PDF)

Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology Group

Journal of clinical oncology, 2014-03, Vol.32 (7), p.647-653

2014

Volltextzugriff (PDF)

Automated assessment of illness and treatment understanding (ITU) via the Memorial Sloan Kettering Patient Portal

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e24146-e24146

2022

Volltextzugriff (PDF)

obesity and metastatic melanoma: A national perspective from the pre-immune checkpoint inhibitor era

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e21032-e21032

2019

Volltextzugriff (PDF)

Phase I trial of enzalutamide (Enz) plus the glucocorticoid receptor antagonist relacorilant (Rela) for patients with metastatic castration resistant prostate cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5062-5062

2023

Volltextzugriff (PDF)

Reply to K. Beiske et al

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3720-3721

2020

Volltextzugriff (PDF)

Spectrum of acquired KRAS mutations in driver mutation-positive non-small cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9069-9069

2023

Volltextzugriff (PDF)

Accuracy of oncology patients’ expectations of cure

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e24167-e24167

2020

Volltextzugriff (PDF)

Health-related values of newly-diagnosed cancer patients: Qualitative analysis of oncology nurse-led discussions

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e24163-e24163

2020

Volltextzugriff (PDF)

Effect of discharge to subacute rehabilitation (SAR) on hospitalized patients with progressive gastrointestinal (GI) cancer

Journal of clinical oncology, 2016-10, Vol.34 (26_suppl), p.41-41

2016

Volltextzugriff (PDF)

Selection of the recommended phase 2 dose (RP2D) for subcutaneous nemvaleukin alfa: ARTISTRY-2

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2552-2552

2021

Volltextzugriff (PDF)

Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10041-10041

2022

Volltextzugriff (PDF)

CRESTONE: Initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3006-3006

2022

Volltextzugriff (PDF)

Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16510-e16510

2021

Volltextzugriff (PDF)

Disrupting end-of-life cancer care delivery: Results from the engagment of patients with advanced cancer trial

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6525-6525

2017

Volltextzugriff (PDF)

Palliative care from cancer diagnosis for all: Memorial Sloan Kettering’s “One-Two-Three” program

Journal of clinical oncology, 2017-11, Vol.35 (31_suppl), p.111-111

2017

Volltextzugriff (PDF)

EGFR testing scenario across 111 centres in India: A questionnaire-based survey

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e13111-e13111

2017

Volltextzugriff (PDF)

Are the survival benefits associated with primary resection in de novo metastatic colorectal cancer (mCRC) mediated by reversal of systemic inflammation?

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.464-464

2014

Volltextzugriff (PDF)

Large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10520-10520

2011

Volltextzugriff (PDF)

Phase I, PK, dose-finding, active controlled study of paclitaxel injection concentrate for nanodispersion (PICN) in subjects with metastatic breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11585-e11585

2011

Volltextzugriff (PDF)

Hyaluronidase synthase 3 ( HAS3 ) variant and anthracycline-related cardiomyopathy: A report from the Children’s Oncology Group

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.10004-10004

2013

Volltextzugriff (PDF)

Tumor SPARC microenvironment signature (SMS) and plasma levels in a phase II trial of unresectable stage IV melanoma treated with nab -paclitaxel and carboplatin: A translational study of NCCTG trial N057E

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8578-8578

2010

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(7)
Child
(5)
Life Sciences & Biomedicine
(5)
Oncology
(5)
Science & Technology
(5)
Original Reports
(4)
Biological And Medical Sciences
(3)
Male
(3)
Medical Sciences
(3)
Tumors
(3)
Adolescent
(2)
Adult
(2)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(2)
Child, Preschool
(2)
Drug Administration Schedule
(2)
Female
(2)
Infant
(2)
Neuroblastoma - Pathology
(2)
Prognosis
(2)
Adenocarcinoma - Drug Therapy
(1)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(47)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(47)
NUS Single-Journal Subscriptions
(47)
IngentaConnect Journals
(15)
Ingenta
(15)
MEDLINE
(7)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project

Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor

Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group

Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology Group

Automated assessment of illness and treatment understanding (ITU) via the Memorial Sloan Kettering Patient Portal

obesity and metastatic melanoma: A national perspective from the pre-immune checkpoint inhibitor era

Phase I trial of enzalutamide (Enz) plus the glucocorticoid receptor antagonist relacorilant (Rela) for patients with metastatic castration resistant prostate cancer

Reply to K. Beiske et al

Spectrum of acquired KRAS mutations in driver mutation-positive non-small cell lung cancer

Accuracy of oncology patients’ expectations of cure

Health-related values of newly-diagnosed cancer patients: Qualitative analysis of oncology nurse-led discussions

Effect of discharge to subacute rehabilitation (SAR) on hospitalized patients with progressive gastrointestinal (GI) cancer

Selection of the recommended phase 2 dose (RP2D) for subcutaneous nemvaleukin alfa: ARTISTRY-2

Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study

CRESTONE: Initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions

Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423)

Disrupting end-of-life cancer care delivery: Results from the engagment of patients with advanced cancer trial

Palliative care from cancer diagnosis for all: Memorial Sloan Kettering’s “One-Two-Three” program

EGFR testing scenario across 111 centres in India: A questionnaire-based survey

Are the survival benefits associated with primary resection in de novo metastatic colorectal cancer (mCRC) mediated by reversal of systemic inflammation?

Large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays

Phase I, PK, dose-finding, active controlled study of paclitaxel injection concentrate for nanodispersion (PICN) in subjects with metastatic breast cancer

Hyaluronidase synthase 3 ( HAS3 ) variant and anthracycline-related cardiomyopathy: A report from the Children’s Oncology Group

Tumor SPARC microenvironment signature (SMS) and plasma levels in a phase II trial of unresectable stage IV melanoma treated with nab -paclitaxel and carboplatin: A translational study of NCCTG trial N057E

Aktive Filter

Suchergebnisse filtern